Skip to main content
. Author manuscript; available in PMC: 2022 Oct 29.
Published in final edited form as: Expert Rev Mol Med. 2022 Jan 28;24:e7. doi: 10.1017/erm.2021.32

Figure 2.

Figure 2.

The schematic diagram of CAR signalling and CAR-T activation (A), the effector function of CAR-Ts to kill tumour cells (B), and the exhaustion/death of CAR-Ts by persistent tumour antigen stimulation (C).